GO:0007519 skeletal muscle tissue development: Myogenesis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0007519 (skeletal muscle tissue development) describes the developmental sequence that builds adult skeletal muscle: myoblast fusion into myotubes, myofibril formation, and establishment of functional neuromuscular junctions.
• The process is driven by the myogenic regulatory factors (MYOD1, MYF5, MYOG, MYF6) and paired-box factors (PAX3, PAX7), which control commitment, differentiation, and fusion of muscle progenitors [2,5].
• Satellite cells are the resident muscle stem cells that sustain postnatal growth and regeneration, and their niche signals are central to muscle homeostasis [5,7].
• Human engineered skeletal muscle models now recapitulate key features of development, regeneration, and dystrophy in vitro, providing tractable platforms for mechanistic and therapeutic studies.
• Single-cell RNA sequencing and single-cell open-chromatin profiling have resolved the cellular trajectories and regulatory programs underlying skeletal muscle development in multiple species [4,6].
• Dysregulation of skeletal muscle development and regeneration contributes to muscular dystrophies, sarcopenia, and metabolic disease, making this GO term a high-value target for CRISPR-based functional genomics [1,7,8].
Description
Skeletal muscle tissue development (GO:0007519) is the developmental program that converts proliferating myoblasts into mature, multinucleated muscle fibers capable of force generation. The QuickGO definition emphasizes three cardinal events: fusion of myoblasts to form myotubes that enlarge by further fusion, assembly of myofibrils within the cytoplasm, and establishment of functional neuromuscular junctions with motor neurons. This process is not restricted to embryogenesis; it is partially recapitulated postnatally during regeneration, when satellite cells activate, proliferate, and differentiate to repair damaged fibers [5,7]. Because the same transcriptional and signaling modules operate in development and regeneration, the term provides a unifying framework for studying muscle biology across the lifespan [2,7]. For researchers, GO:0007519 is a practical annotation anchor. Genes assigned to this term are enriched for myogenic transcription factors, cytoskeletal and sarcomeric proteins, cell-fusion machinery, and extracellular matrix components that shape the stem-cell niche [2,5]. Modern single-cell and single-nucleus approaches have refined this picture by mapping developmental trajectories and open-chromatin dynamics in human, bovine, and other systems, revealing both conserved and species-specific regulatory logic [4,6]. Engineered human skeletal muscle tissues now allow these programs to be interrogated in vitro with genetic perturbations, including CRISPR-based knockout and knock-in, linking genotype to myogenic phenotype. This article summarizes the authoritative definition, the major biological stages, the key genes, the regulatory inputs, and the disease connections of GO:0007519. It also outlines how CRISPR models and multi-omic methods can be used to dissect the term experimentally, with the goal of supporting publication-grade research design and reproducible annotation.
skeletal muscle tissue development At A Glance
| GO ID | GO:0007519 |
|---|---|
| GO term | skeletal muscle tissue development |
| Ontology | biological_process |
| Synonym | myogenesis |
| Major function | Formation of mature skeletal muscle fibers through myoblast fusion, myofibril assembly, and neuromuscular junction formation |
| Definition source | QuickGO definition, based on the developmental sequence of adult skeletal muscle tissue formation |
| Key cell types | Myoblasts, myotubes, myofibers, satellite cells, motor neurons |
| Representative regulators | MYOD1, MYF5, MYOG, MYF6, PAX3, PAX7 |
| Related processes | Muscle regeneration, satellite cell activation, sarcomere assembly, neuromuscular junction formation |
What Is GO:0007519?
In plain terms, GO:0007519 describes how the body builds skeletal muscle tissue. According to the QuickGO definition, it is the developmental sequence of events leading to the formation of adult skeletal muscle tissue. The main events are the fusion of myoblasts to form myotubes that increase in size by further fusion to them of myoblasts, the formation of myofibrils within their cytoplasm, and the establishment of functional neuromuscular junctions with motor neurons. At this stage the cells can be regarded as mature muscle fibers. The synonym myogenesis is commonly used for this process.
Why Is skeletal muscle tissue development Important in Cell Biology?
GO:0007519 matters because skeletal muscle is essential for locomotion, posture, breathing, and whole-body metabolism, and because failures in its development or regeneration underlie major human diseases. The term captures the core cell-fate transitions and morphogenetic events that researchers must understand to model muscular dystrophies, sarcopenia, and metabolic disorders. Because satellite cells and their niche regulate postnatal muscle maintenance and repair, the same developmental logic informs regenerative medicine and tissue-engineering strategies [5,7]. Engineered human muscle models that recapitulate development, regeneration, and dystrophy now make it possible to test causal hypotheses about genes annotated to this term in a controlled setting.
• Defines the core developmental program that produces functional, multinucleated skeletal muscle fibers.
• Provides the mechanistic basis for muscle regeneration, since satellite cell activation and differentiation reuse developmental regulators [5,7].
• Underpins understanding of muscular dystrophies, where muscle development and repair are impaired.
• Connects to metabolic homeostasis, as skeletal muscle is a major site of energy and creatine metabolism.
• Links to adipose-derived signals that modulate muscle development and homeostasis.
• Supports single-cell atlas efforts that map myogenic trajectories and regulatory elements [4,6].
• Offers a framework for CRISPR functional genomics of myogenic genes and regulatory elements.
• Informs tissue engineering and cell therapy approaches for muscle loss and injury [1,5].
• Helps interpret disease variants in genes controlling myoblast fusion and sarcomere assembly [2,7].
• Guides annotation and enrichment analyses in muscle transcriptomic and epigenomic studies [4,6].
What Happens During skeletal muscle tissue development?
Myogenic commitment and progenitor specification
In simple terms: First, precursor cells are instructed to become muscle cells.
Skeletal muscle development begins when multipotent progenitors acquire a myogenic identity under the control of paired-box factors PAX3 and PAX7 and the myogenic regulatory factors MYF5 and MYOD1 [2,5]. These transcription factors establish the myoblast state and are maintained in satellite cells, the postnatal muscle stem cells that occupy a defined niche beneath the basal lamina. Single-cell transcriptomic studies have resolved these commitment steps and identified progenitor populations that seed developing muscle tissue [4,6].
Myoblast proliferation and cell-cycle exit
In simple terms: Muscle precursor cells multiply, then stop dividing before they fuse.
Committed myoblasts proliferate to expand the progenitor pool, then exit the cell cycle in response to differentiation cues. This transition is coordinated by MYOD1 and MYOG, which activate muscle-specific gene expression while restraining proliferation programs. The balance between proliferation and differentiation is critical, because premature or delayed exit alters final fiber number and size, and dysregulation of this step is linked to impaired regeneration [5,7].
Myoblast fusion and myotube formation
In simple terms: Many small muscle cells merge into larger, multi-nucleus tubes.
The QuickGO definition places myoblast fusion at the center of GO:0007519: myoblasts fuse to form myotubes, which then increase in size by further fusion of additional myoblasts. Fusion requires recognition, adhesion, and membrane-merging machinery, and it depends on the continued activity of myogenic transcription factors such as MYOG and MYF6. The resulting multinucleated syncytia provide the structural template for the mature fiber.
Myofibril and sarcomere assembly
In simple terms: Inside the tubes, contractile cables are built.
Within the cytoplasm of the myotube, myofibrils assemble and mature into sarcomeres, the repeating contractile units that contain actin and myosin filaments and their associated structural proteins. This step converts a multinucleated cell into a mechanically functional fiber and is a defining feature of the term. Defects in sarcomeric protein expression or assembly impair contractility and are associated with muscle disease [1,2].
Neuromuscular junction formation and maturation
In simple terms: The new muscle fiber connects to motor neurons so the brain can control it.
The QuickGO definition explicitly includes establishment of functional neuromuscular junctions with motor neurons as a main event of skeletal muscle tissue development. Motor neuron innervation patterns the postsynaptic apparatus and supports fiber maturation and subtype specification. This neuro-muscular coupling is essential for coordinated movement and for the trophic support that maintains mature muscle fibers [2,5].
Postnatal growth, regeneration, and niche control
In simple terms: After birth, resident stem cells keep repairing and growing muscle.
Satellite cells reside in a specialized niche and can re-enter the myogenic program after injury, recapitulating developmental steps such as activation, proliferation, and fusion [5,7]. Niche-derived signals, including those from adjacent cell types and systemic factors, regulate this process, and adipose-derived adipokines and lipokines have been implicated in modulating skeletal muscle development and homeostasis. Engineered human muscle models reproduce key features of development, regeneration, and dystrophy, enabling controlled study of these events.
Key Genes Involved in GO:0007519 skeletal muscle tissue development
The following genes are representative regulators and effectors of skeletal muscle tissue development (GO:0007519), spanning myogenic transcription, progenitor maintenance, fusion, sarcomere assembly, and niche signaling.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MYOD1 | Core myogenic regulatory factor that drives myoblast determination and differentiation | Central marker and perturbation target for myogenic commitment studies |
| MYF5 | Myogenic regulatory factor required for early myoblast specification | Frequently assessed in developmental and satellite cell studies [2,5] |
| MYOG | Myogenin, promotes terminal differentiation and myoblast fusion | Key readout of differentiation and fusion assays |
| MYF6 | Myogenic factor 6, supports myotube maturation and fiber maintenance | Candidate for maturation and fusion studies |
| PAX3 | Paired-box transcription factor for progenitor specification | Used to trace embryonic myogenic lineages [2,5] |
| PAX7 | Satellite cell marker and regulator of muscle stem cell maintenance | Core target for regeneration and stem-cell niche research [5,7] |
| MYH1 | Myosin heavy chain isoform of fast fibers | Fiber-type and sarcomere assembly readout |
| MYH2 | Myosin heavy chain isoform contributing to contractile apparatus | Marker of mature myofiber identity |
| ACTA1 | Skeletal muscle actin, principal thin filament component | Sarcomere assembly and contractility studies |
| MYL1 | Myosin light chain involved in sarcomere function | Structural and functional maturation marker |
| TNNT3 | Troponin T isoform regulating calcium-dependent contraction | Contractile regulation and disease modeling |
| DES | Desmin, intermediate filament protein linking myofibrils | Cytoskeletal organization and myofibril integrity |
| DMD | Dystrophin, links cytoskeleton to extracellular matrix | Dystrophy modeling and membrane stability studies |
| CREB1 | Transcription factor contributing to muscle gene regulation | Signaling-to-transcription studies in myogenesis |
| MEF2C | MADS-box factor cooperating with myogenic regulators | Enhancer and differentiation network analysis |
| IGF1 | Growth factor promoting myoblast proliferation and differentiation | Anabolic and regeneration studies |
| ADIPOQ | Adipokine influencing muscle development and homeostasis | Adipose-muscle crosstalk research |
How Is skeletal muscle tissue development Regulated?
Skeletal muscle tissue development is regulated at multiple levels. Transcriptional control is exerted by the myogenic regulatory factors MYOD1, MYF5, MYOG, and MYF6 together with PAX3, PAX7, and MEF2 family factors, which establish and reinforce the myogenic program [2,5]. Signaling inputs from growth factors and metabolic cues modulate the balance between progenitor proliferation and differentiation, and creatine-related metabolism has been reviewed in the context of skeletal muscle metabolism and muscle mass regulation. Adipose-derived adipokines and lipokines add an endocrine layer of control over muscle development and homeostasis. In the postnatal niche, satellite cell quiescence, activation, and self-renewal are governed by local and systemic signals that recapitulate developmental regulatory logic [5,7]. Single-cell chromatin and transcriptome studies have begun to define the enhancer landscapes through which these regulators act [4,6].
skeletal muscle tissue development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DMD | Duchenne muscular dystrophy and membrane instability | Knockout or point-mutation myogenic cell model with contractility readouts |
| PAX7 | Satellite cell dysfunction and impaired regeneration | Knockout and tagged knock-in for lineage tracing [5,7] |
| MYOG | Defective myoblast fusion and differentiation | Knockout and overexpression in differentiation assays |
| MYOD1 | Loss of myogenic commitment | Knockout with transcriptomic and imaging readouts |
| ADIPOQ | Adipose-muscle crosstalk in metabolic disease | Overexpression and knockout in co-culture systems |
Muscular dystrophies and myopathies
Duchenne muscular dystrophy and related disorders arise from defects in proteins that maintain sarcolemmal integrity and myofiber function, and they impair the normal developmental and regenerative program captured by GO:0007519. Engineered human skeletal muscle models that recapitulate development, regeneration, and dystrophy provide platforms to study these defects and to test corrective interventions.
Muscle wasting, sarcopenia, and metabolic disease
Loss of muscle mass and function in aging and chronic disease reflects dysregulation of the pathways that build and maintain muscle fibers. Metabolic and endocrine signals, including adipose-derived adipokines and lipokines, influence skeletal muscle development and homeostasis, linking this GO term to metabolic disease biology. Creatine metabolism is also relevant to muscle mass regulation and has been reviewed in this context.
Regeneration failure and stem cell dysfunction
When satellite cells fail to activate, proliferate, or differentiate appropriately, muscle repair is compromised. Because regeneration reuses developmental regulators, defects in the machinery of GO:0007519 manifest as impaired regeneration and progressive weakness [5,7]. Understanding niche control of satellite cells is therefore central to therapeutic strategies for muscle injury and degenerative disease.
From skeletal muscle tissue development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for myoblast fusion? | CRISPR knockout in myogenic cells followed by fusion index quantification |
| Does a disease-associated variant alter myogenic differentiation? | Point-mutation knock-in of the variant with differentiation and RNA-seq readouts |
| Where and when is a myogenic regulator expressed? | Tagged knock-in with fluorescent or epitope tag for imaging and proteomics |
| Does overexpression of a factor enhance muscle formation? | Overexpression cell model with myotube morphology and sarcomere markers |
| Which enhancers control a myogenic gene program? | CRISPR perturbation of candidate regulatory elements with single-cell readouts |
| How do niche signals affect satellite cell activation? | Co-culture and conditioned-medium models with knockout or knock-in perturbations [5,7] |
How to Study the skeletal muscle tissue development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Single-cell RNA sequencing | Cell-type composition and differentiation trajectories | Mapping myogenic progression in development and regeneration [4,6] |
| Single-cell ATAC sequencing | Open-chromatin regions and candidate regulatory elements | Enhancer discovery in myogenesis |
| Immunofluorescence | Protein localization and fusion index | Validation of differentiation and sarcomere assembly |
| Engineered muscle tissue assay | Contractility and tissue maturation | Disease modeling and drug testing |
| Bulk RNA sequencing | Global transcriptional changes after perturbation | Knockout and overexpression phenotyping |
| Proteomics | Protein abundance and interactions in myotubes | Mechanistic follow-up of candidate genes |
| Lineage tracing | Origin and fate of myogenic progenitors | Satellite cell and developmental studies [5,7] |
| Co-culture systems | Niche and endocrine effects on myogenesis | Adipose-muscle crosstalk and regeneration studies |
Single-cell transcriptomics and trajectory analysis
Single-cell RNA sequencing resolves the cellular heterogeneity of developing and regenerating muscle and reconstructs differentiation trajectories from progenitors to myotubes and fibers. Applied to bovine and other species, it has revealed conserved and species-specific regulatory programs in skeletal muscle development.
Single-cell open-chromatin and regulatory element mapping
Assays for open chromatin at single-cell resolution identify enhancers and promoters active during myogenesis, connecting transcription factor binding to gene expression. These data help prioritize noncoding elements for CRISPR perturbation studies of GO:0007519.
Engineered human muscle tissue models
Engineered skeletal muscle tissues derived from human cells recapitulate key features of development, regeneration, and dystrophy, enabling controlled genetic and pharmacological experiments. These models support functional readouts such as contractility, fusion index, and sarcomere organization.
Imaging and molecular markers of differentiation
Immunofluorescence for myogenic transcription factors, sarcomeric proteins, and fusion markers allows staging of myoblast commitment, myotube formation, and myofibril assembly. Combined with live imaging, these approaches link gene perturbation to morphogenetic outcomes.
How CRISPR Can Be Used to Study GO:0007519 skeletal muscle tissue development
Knockout
CRISPR knockout of genes annotated to GO:0007519, such as MYOD1, MYOG, or PAX7, allows direct testing of requirement for commitment, fusion, and differentiation in myogenic cell models [2,5]. Knockout phenotypes can be scored by fusion index, sarcomere staining, and transcriptomic profiling.
Point Mutation
Point-mutation knock-in can model disease-associated variants in sarcomeric or membrane-associated genes and assess their impact on myofiber function and stability. This approach is valuable when complete loss of function is incompatible with viability or does not reflect the human genotype.
Knock-in
Tagged knock-in of endogenous loci, for example with fluorescent or epitope tags, enables visualization and biochemical isolation of myogenic regulators at native expression levels. Knock-in of reporter cassettes can also provide sensitive readouts of differentiation state.
Overexpression
Overexpression of candidate regulators, such as growth factors or transcription factors, tests sufficiency for enhancing myoblast fusion, myotube size, or sarcomere assembly. Overexpression models complement loss-of-function studies to establish causal direction.
How EDITGENE Supports skeletal muscle tissue development Research
Researchers studying skeletal muscle tissue development-related genes often need to determine whether a candidate gene is causally involved in myoblast commitment, fusion, myofibril assembly, or neuromuscular junction formation, rather than merely correlated with these processes. EDITGENE provides publication-grade CRISPR cell models and screening services designed to answer these causal questions in myogenic systems.
Contact EDITGENE today to design your custom CRISPR model for skeletal muscle tissue development research.
Frequently Asked Questions About skeletal muscle tissue development
What is GO:0007519 skeletal muscle tissue development?
GO:0007519 is a Gene Ontology biological process term describing the developmental sequence that forms adult skeletal muscle tissue, including myoblast fusion into myotubes, myofibril formation, and establishment of functional neuromuscular junctions with motor neurons.
What genes are involved in skeletal muscle tissue development?
Key genes include the myogenic regulatory factors MYOD1, MYF5, MYOG, and MYF6, the paired-box factors PAX3 and PAX7, and structural genes such as ACTA1, MYH1, MYH2, DES, and DMD [2,5].
What are the main steps of myogenesis?
The main steps are myogenic commitment, myoblast proliferation and cell-cycle exit, myoblast fusion into myotubes, myofibril and sarcomere assembly, and neuromuscular junction formation, followed by postnatal growth and regeneration [2,5].
How do satellite cells contribute to skeletal muscle development and regeneration?
Satellite cells are resident muscle stem cells that can activate, proliferate, and differentiate to repair fibers, reusing developmental regulators, and their behavior is controlled by the niche [5,7].
Which diseases are linked to defects in skeletal muscle tissue development?
Muscular dystrophies such as Duchenne muscular dystrophy, muscle wasting and sarcopenia, and metabolic disorders involving adipose-muscle crosstalk have been linked to impaired muscle development and regeneration [1,8].
How can CRISPR be used to study skeletal muscle tissue development?
CRISPR knockout, point-mutation knock-in, tagged knock-in, and overexpression models allow causal testing of candidate genes in myoblast differentiation, fusion, and sarcomere assembly assays [1,2].
What methods are used to study myogenesis?
Common methods include single-cell RNA sequencing, single-cell ATAC sequencing, immunofluorescence, engineered muscle tissue assays, bulk RNA sequencing, proteomics, and lineage tracing [1,4,6].
What is the role of MYOD1 in skeletal muscle development?
MYOD1 is a core myogenic regulatory factor that drives myoblast determination and differentiation and is a central marker and perturbation target in myogenesis research.
Why is single-cell sequencing important for muscle development research?
Single-cell approaches resolve cellular heterogeneity and reconstruct differentiation trajectories and regulatory element activity during muscle development and regeneration [4,6].
Can engineered human muscle models recapitulate muscle development?
Yes, engineered skeletal muscle tissues have been shown to recapitulate key features of human muscle development, regeneration, and dystrophy, supporting mechanistic and therapeutic studies.
Conclusion
GO:0007519 skeletal muscle tissue development provides a precise, ontology-based framework for studying how myoblasts become mature, innervated muscle fibers. Its core events, myoblast fusion, myofibril assembly, and neuromuscular junction formation, are controlled by a well-defined set of myogenic transcription factors and are recapitulated during regeneration by satellite cells [2,5,7]. Single-cell and engineered-tissue technologies have greatly expanded the experimental toolkit for this term, enabling trajectory mapping and functional testing in human-relevant systems [1,4,6]. Because defects in these processes underlie muscular dystrophies, muscle wasting, and metabolic disease, causal gene-to-phenotype studies remain a high priority [1,8]. CRISPR-based knockout, point-mutation, knock-in, and overexpression models, combined with library screening and bioinformatic integration, offer a direct route to identifying which genes and regulatory elements truly drive skeletal muscle tissue development.
References
- 1. Shahriyari M et al.. 2022. Engineered skeletal muscle recapitulates human muscle development, regeneration and dystrophy.. J Cachexia Sarcopenia Muscle 13(6):3106-3121 PMID: 36254806
- 2. Chal J et al.. 2017. Making muscle: skeletal myogenesis in vivo and in vitro.. Development 144(12):2104-2122 PMID: 28634270
- 3. Farshidfar F et al.. 2017. Creatine Supplementation and Skeletal Muscle Metabolism for Building Muscle Mass- Review of the Potential Mechanisms of Action.. Curr Protein Pept Sci 18(12):1273-1287 PMID: 28595527
- 4. Cai C et al.. 2023. Single-cell RNA sequencing in skeletal muscle developmental biology.. Biomed Pharmacother 162:114631 PMID: 37003036
- 5. Yin H et al.. 2013. Satellite cells and the muscle stem cell niche.. Physiol Rev 93(1):23-67 PMID: 23303905
- 6. Cai C et al.. 2023. Transcriptional and open chromatin analysis of bovine skeletal muscle development by single-cell sequencing.. Cell Prolif 56(9):e13430 PMID: 36855961
- 7. Chargé SB et al.. 2004. Cellular and molecular regulation of muscle regeneration.. Physiol Rev 84(1):209-38 PMID: 14715915
- 8. Gu X et al.. 2023. Adipose tissue adipokines and lipokines: Functions and regulatory mechanism in skeletal muscle development and homeostasis.. Metabolism 139:155379 PMID: 36538987
